On January 30th, GENOR-B (06998) spent 2.537 million Hong Kong dollars to repurchase 1 million shares.
Jiahe Bio (06998) announced that on January 30, 2026, the company spent 2.537 million Hong Kong dollars to repurchase 1 million shares at a repurchase price of 2.47-2.56 Hong Kong dollars per share.
GENOR-B (06998) Announces that on January 30, 2026, the company will spend 2.537 million Hong Kong dollars to repurchase 1 million shares, with a repurchase price of 2.47-2.56 Hong Kong dollars per share.
Related Articles
US Stock Market Move | Micron Technology, Inc. (MU.US) rises nearly 4% as the three major global memory chip giants join forces to impose restrictions on sales to prevent hoarding by downstream customers.
QINGHUA HOLD (08082) exercised its right to purchase shares and issued 20.9 million shares.
ZGC TEC LEASING (01601) enters into a purchase agreement and a financing lease agreement.
US Stock Market Move | Micron Technology, Inc. (MU.US) rises nearly 4% as the three major global memory chip giants join forces to impose restrictions on sales to prevent hoarding by downstream customers.
QINGHUA HOLD (08082) exercised its right to purchase shares and issued 20.9 million shares.
ZGC TEC LEASING (01601) enters into a purchase agreement and a financing lease agreement.
RECOMMEND
Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026
Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026
2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026
